Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
National Institute for Public Health and the Environment
De Bilt, HolandaNational Institute for Public Health and the Environment-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341